SRC
Sage Rhino Capital Portfolio holdings
AUM
$473M
This Quarter Return
+17.41%
1 Year Return
+18.22%
3 Year Return
+65.67%
5 Year Return
+96.93%
10 Year Return
–
AUM
$253M
AUM Growth
+$253M
(+22%)
Cap. Flow
+$14.1M
Cap. Flow
% of AUM
5.56%
Top 10 Holdings %
Top 10 Hldgs %
42.25%
Holding
182
New
15
Increased
88
Reduced
52
Closed
4
Top Buys
| 1 |
DocuSign
DOCU
|
$10.3M |
| 2 |
Lyft
LYFT
|
$1.09M |
| 3 |
Uber
UBER
|
$766K |
| 4 |
Boeing
BA
|
$553K |
| 5 |
Salesforce
CRM
|
$469K |
Top Sells
| 1 |
DaVita
DVA
|
$1.24M |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
$390K |
| 3 |
Vanguard Health Care ETF
VHT
|
$336K |
| 4 |
Biogen
BIIB
|
$222K |
| 5 |
GSK
GSK
|
$214K |
Sector Composition
| 1 | Technology | 18.17% |
| 2 | Consumer Discretionary | 4.17% |
| 3 | Healthcare | 3.55% |
| 4 | Financials | 3.1% |
| 5 | Communication Services | 2.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Broadcom
AVGO
$1.42T
| $428K | 0.17% |
9,770
+210
| +2% | +$9.2K |
|
102
Invesco S&P 500 Pure Growth ETF
RPG
$1.71B
| $425K | 0.17% |
13,045
-2,850
| -18% | -$92.9K |
|
103
KKR & Co
KKR
$120B
| $423K | 0.17% |
10,455
| – | – |
|
|
CONE
104
DELISTED
CyrusOne Inc Common Stock
CONE
| $416K | 0.16% |
5,684
+4
| +0.1% | +$293 |
|
105
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $405K | 0.16% |
8,573
| – | – |
|
106
Toyota
TM
$252B
| $389K | 0.15% |
2,518
+24
| +1% | +$3.71K |
|
107
iShares Core S&P Mid-Cap ETF
IJH
$99.4B
| $386K | 0.15% |
8,400
| – | – |
|
108
Walt Disney
DIS
$211B
| $385K | 0.15% |
2,127
+85
| +4% | +$15.4K |
|
109
AstraZeneca
AZN
$255B
| $382K | 0.15% |
7,638
-2,403
| -24% | -$120K |
|
110
Schwab U.S Small- Cap ETF
SCHA
$18.4B
| $379K | 0.15% |
17,036
| – | – |
|
111
iShares MSCI Europe Financials ETF
EUFN
$4.32B
| $368K | 0.15% |
+21,000
| New | +$368K |
|
112
Medtronic
MDT
$118B
| $361K | 0.14% |
3,083
+49
| +2% | +$5.74K |
|
113
Unilever
UL
$158B
| $360K | 0.14% |
+5,956
| New | +$360K |
|
114
Autodesk
ADSK
$67.6B
| $345K | 0.14% |
1,130
-1
| -0.1% | -$305 |
|
115
Illumina
ILMN
$15.2B
| $344K | 0.14% |
957
+2
| +0.2% | +$719 |
|
116
Eli Lilly
LLY
$661B
| $340K | 0.13% |
2,016
+46
| +2% | +$7.76K |
|
117
Mastercard
MA
$536B
| $334K | 0.13% |
936
+34
| +4% | +$12.1K |
|
118
iShares Core S&P Small-Cap ETF
IJR
$84.4B
| $330K | 0.13% |
3,594
| – | – |
|
119
BP
BP
$88.8B
| $324K | 0.13% |
15,791
+1,787
| +13% | +$36.7K |
|
120
Abbott
ABT
$230B
| $316K | 0.12% |
2,886
-167
| -5% | -$18.3K |
|
121
Sanofi
SNY
$122B
| $316K | 0.12% |
6,510
+135
| +2% | +$6.55K |
|
122
Sony
SONY
$162B
| $314K | 0.12% |
15,520
-70
| -0.4% | -$1.42K |
|
123
Thermo Fisher Scientific
TMO
$183B
| $312K | 0.12% |
670
+2
| +0.3% | +$931 |
|
124
Novo Nordisk
NVO
$252B
| $310K | 0.12% |
8,878
+14
| +0.2% | +$489 |
|
125
NVIDIA
NVDA
$4.15T
| $308K | 0.12% |
23,560
+320
| +1% | +$4.18K |
|